Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMPIRE: Red Heart Pill for CVD Prevention
NCT01057537Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Jun 2010
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of aspirin, simvastatin, lisinopril, atenolol, hydrochlorothiazide in cardiovascular disease (CVD), sponsored by Imperial College London. Started Jun 2010; status: completed.
02
Drugs
aspirinsimvastatinlisinoprilatenololhydrochlorothiazide
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01057537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01057537.